IP Library › Granted Patent US 11,525,629
Granted Patent B2
US 11,525,629 · App. 17/167,527 · Granted Dec 13, 2022

Target residual moisture content for lyophilized drug product

Inventors: Xiaolin Tang (Old Tappan, NJ); Mary Kleppe (Milford, CT); Ravi Chari (Norwich, CT); Franco Tzul (Hartsdale, NY)
Assignee: Regeneron Pharmaceuticals, Inc.
F26B5/06A61K9/19
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,525,629
App. No.
17/167,527
Granted
Dec 13, 2022
Kind
B2
Abstract

Lyophilization methods for preparing protein formulations for long-term storage at room temperature or improved stability at refrigeration storage are provided. Specifically, the present application provides lyophilization methods to obtain a target percentage of residual moisture of a lyophilized product, such as 3-5% residual moisture. The secondary drying of the lyophilization can be conducted under controlling rate of desorption under a temperature which is similar to the shelf temperature of the primary drying. Alternatively, the lyophilization can be conducted without a distinguished secondary drying step.

Claims (26)

1. A method of preparing a lyophilized cake, comprising:

preparing a formulation, wherein the formulation comprises at least one solvent molecule and a peptide or protein;

subjecting the formulation to lyophilization to obtain the lyophilized cake, including:

placing the formulation in a chamber of a freeze-dryer,

freezing the formulation,

conducting first drying on the formulation to remove the at least one frozen solvent molecule by sublimation, wherein the first drying is conducted at a shelf temperature of the freeze-dryer that is equal to or below about 0° C., and

conducting second drying on the formulation to remove the at least one solvent molecule to obtain a target weight percentage of the at least one solvent molecule in the lyophilized cake, wherein the second drying is conducted at the shelf temperature of the freeze-dryer that is equal to or below 0° C.

2. The method of claim 1 , wherein the target weight percentage of the at least one solvent molecule in the lyophilized cake is controlled by the shelf temperature of the freeze-dryer for the second drying with a controlled drying rate.

3. The method of claim 1 , wherein the target weight percentage of the at least one solvent molecule in the lyophilized cake is controlled by a duration time for the second drying.

4. The method of claim 1 , wherein the shelf temperature of the freeze-dryer for the second drying is equal to or slightly higher than the shelf temperature of the freeze-dryer for the first drying.

5. The method of claim 1 , wherein the shelf temperature of the freeze-dryer for the second drying is same as the shelf temperature of the freeze-dryer for the first drying.

6. The method of claim 1 , wherein the shelf temperature of the freeze-dryer for the second drying is higher than the shelf temperature of the freeze-dryer for the first drying.

7. The method of claim 1 , wherein the shelf temperature of the freeze-dryer for the second drying is lower than the shelf temperature of the freeze-dryer for the first drying.

8. The method of claim 1 , wherein the target weight percentage of the at least one solvent molecule in the lyophilized cake is about 3-5%, about 4% or about 4.5%.

9. The method of claim 1 , wherein the peptide or protein is an antibody, an antibody fragment, a Fab region of an antibody, an antibody-drug conjugate, a fusion protein, a protein pharmaceutical product or a drug.

10. The method of claim 1 , wherein the lyophilized cake is stable under the storage condition at room temperature or has improved stability for refrigeration storage.

11. The method of claim 1 , the at least one solvent molecule is a water molecule.

12. The method of claim 1 further comprising determining an ending of the first drying based on a change of a pressure in the chamber of the freeze-dryer.

13. The method of claim 1 , wherein a temperature of the lyophilized cake is below a collapse temperature of the lyophilized cake in the first drying.

14. The method of claim 1 , wherein the formulation further comprises a buffer, an excipient, a stabilizer, a cryo-protectant, a bulking agent, a plasticizer, or a combination thereof.

15. The method of claim 14 , wherein the buffer comprises acetate and/or histidine hydrochloride.

16. The method of claim 14 , wherein the buffer has a pH value of about 5.3 or about 6.

17. The method of claim 14 , wherein the excipient is polysorbate 80.

18. The method of claim 14 , wherein the stabilizer is sucrose, wherein the ratio of sucrose to the peptide or protein is about 1:1, about 3:1, about 10:1, or about from 1:1 to 10:1.

19. The method of claim 14 , wherein the stabilizer is polyol, sucrose, mannitol, trehalose, sorbitol, amino acid, or a combination thereof.

20. The method of claim 14 , wherein the cryo-protectant is surfactant, sugar, salt, amino acid, or a combination thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2022
From: TANG, XIAOLIN; KLEPPE, MARY; CHARI, RAVI; TZUL, FRANCO
To: REGENERON PHARMACEUTICALS, INC.
Reel/Frame 061414/0678 →
Continuity (2)
Provisional Application 62969961 · Feb 4, 2020
Related Publication 20210239396A1 · Aug 5, 2021
Cited By (1)
US 12,449,198